asthma chronic obstructive pulmonary disease highly prevalent economically important inflammatory airway diseases associated mucus hypersecretion considerable additional morbidity mortality related acute exacerbations associated mucus hypersecretion muc5ac prominent airway mucin signalling pathways regulating muc5ac hypersecretion fully characterised investigated signalling pathway regulating phorbol 13acetate muc5ac gene protein expression human respiratory epithelial cells using cells demonstrated treatment pma increased production total mucin proteins increase dependent novo muc5ac gene transcription identified short proximal region muc5ac promoter essential activity containing specificity protein sp NUMBER transcription sites single caccc site chemical inhibition promoter mutagenesis electrophoretic assay emsa demonstrated pma induced proteins binding sp1 sites required induction muc5ac promoter activity demonstrated signalling pathway exclusively activated upstream sp1 activating promoter confirmed requirement matrix metalloproteinase activation leading activation epidermal growth factor receptor finally demonstrated activation novel protein kinase c isoforms delta theta required upstream metalloproteinase activation characterised signalling pathway regulating pma induction muc5ac studies identify key signalling intermediates targets pharmacological intervention treat mucus hypersecretion NUMBER myristate pma induced nci h292 muc5ac specific factor binding site directed mobility shift ras raf ligand dependent mek erk